VSee Health, Inc. Business Acquisition, Pro Forma Revenue
VSee Health, Inc. (VSEE) reported Business Acquisition, Pro Forma Revenue of $12.96 million for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Income Statement › Other Income
us-gaap:BusinessAcquisitionsProFormaRevenue · last filed 2026-03-31
- VSee Health, Inc. business acquisition, pro forma revenue for the quarter ending 2024-12-31 was $3.76M, a 22.35% increase year-over-year.
- VSee Health, Inc. business acquisition, pro forma revenue for the quarter ending 2024-09-30 was $3.35M, a 9.04% increase year-over-year.
- VSee Health, Inc. business acquisition, pro forma revenue for the quarter ending 2024-06-30 was $2.70M, a 2.45% decline year-over-year.
- VSee Health, Inc. business acquisition, pro forma revenue for the quarter ending 2023-12-31 was $3.08M.
- VSee Health, Inc. business acquisition, pro forma revenue for fiscal 2024 was $12.96M, a 3.92% increase from fiscal 2023.
- VSee Health, Inc. business acquisition, pro forma revenue for fiscal 2023 was $12.47M.
| Period end | Business Acquisition, Pro Forma Revenue 3 month | Business Acquisition, Pro Forma Revenue 6 month | Business Acquisition, Pro Forma Revenue 9 month | Business Acquisition, Pro Forma Revenue 12 month |
|---|---|---|---|---|
| 2024-12-31 | $3.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $7.12M derived: sum of 2 quarters · filed 2026-03-31 | $9.82M derived: sum of 3 quarters · filed 2026-03-31 | $12.96M 10-K · filed 2026-03-31 |
| 2024-09-30 | $3.35M 10-Q · filed 2024-11-14 | $6.06M derived: sum of 2 quarters · filed 2024-11-14 | $9.19M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $2.70M 10-Q · filed 2024-09-23 | $5.84M 10-Q · filed 2024-09-23 | ||
| 2023-12-31 | $3.08M derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-08-29 | $6.15M derived: sum of 2 quarters · filed 2025-08-29 | $8.92M derived: sum of 3 quarters · filed 2025-08-29 | $12.47M 10-K/A · filed 2025-08-29 |
| 2023-09-30 | $3.08M 10-Q · filed 2024-11-14 | $5.85M derived: sum of 2 quarters · filed 2024-11-14 | $9.39M 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $2.77M 10-Q · filed 2024-09-23 | $6.31M 10-Q · filed 2024-09-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Agape ATP Corp (ATPC) | $0.002B | ||
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |